Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complication in Systemic Lupus Erythematosus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04424602
What this trial is testing

Comparison between2 Drugs in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Al-Azhar University 40
Not applicableLooking for participantsNCT06631404
What this trial is testing

Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients

Who this might be right for
Lupus Nephritis
Sohag University 55
Not applicableStudy completedNCT01731054
What this trial is testing

Functional MRI in Lupus Nephritis

Who this might be right for
HealthyLupus Nephritis
Biogen 50
Not applicableNot Yet RecruitingNCT06610422
What this trial is testing

Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients

Who this might be right for
Lupus Nephritis
Assiut University 159
Testing effectiveness (Phase 2)Study completedNCT00001212
What this trial is testing

Drug Therapy in Lupus Nephropathy

Who this might be right for
Nephrotic SyndromeSystemic Lupus Erythematosus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 45
Post-approval studies (Phase 4)UnknownNCT05933213
What this trial is testing

Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis

Who this might be right for
Lupus Nephritis
Xiangya Hospital of Central South University 205
Not applicableStudy completedNCT03031925
What this trial is testing

Detection of Annexin A2 in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis
Centre Hospitalier Universitaire, Amiens 120
Not applicableStudy completedNCT04645589
What this trial is testing

Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 69
Post-approval studies (Phase 4)WithdrawnNCT01926054
What this trial is testing

ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis

Who this might be right for
SLE Glomerulonephritis Syndrome, WHO Class V
Ohio State University
Testing effectiveness (Phase 2)Ended earlyNCT01499355
What this trial is testing

BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Biogen 276
Very early researchLooking for participantsNCT06653556
What this trial is testing

LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 34
Not applicableNot Yet RecruitingNCT07706998
What this trial is testing

Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis

Who this might be right for
Learning
Nanjing University 50
Not applicableLooking for participantsNCT05567198
What this trial is testing

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Who this might be right for
Systemic Lupus Erythematosus (Sle)Primary Ovarian Insufficiency (Poi)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 100
Large-scale testing (Phase 3)Looking for participantsNCT06406205
What this trial is testing

QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Qilu Pharmaceutical Co., Ltd. 270
Very early researchStudy completedNCT03027674
What this trial is testing

Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud

Who this might be right for
Raynaud Phenomenon Due to TraumaRaynaud DiseaseSystem; Sclerosis+3 more
Pontificia Universidad Catolica de Chile 10
Not applicableStudy completedNCT02453997
What this trial is testing

Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis

Who this might be right for
Lupus Nephritis
The University of Hong Kong 88
Large-scale testing (Phase 3)Study completedNCT00035308
What this trial is testing

Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease

Who this might be right for
Immunologic DiseasesAutoimmune DiseasesSystemic Lupus Erythematosus+2 more
La Jolla Pharmaceutical Company 330
Not applicableStudy completedNCT03664908
What this trial is testing

Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)?

Who this might be right for
Lupus Nephritis
CHU de Reims 100
Post-approval studies (Phase 4)Looking for participantsNCT07700940
What this trial is testing

The Efficacy of Empagliflozin on Kidney Functions in Lupus Nephritis Population

Who this might be right for
Lupus Nephritis (LN)
Ahmed Yehia Ismail 66
Testing effectiveness (Phase 2)Study completedNCT01273389
What this trial is testing

An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Janssen Research & Development, LLC 25
Next Page